Yuanlong Hu

ORCID: 0000-0003-0534-4112
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammasome and immune disorders
  • Gout, Hyperuricemia, Uric Acid
  • Sirtuins and Resveratrol in Medicine
  • Medicinal Plants and Bioactive Compounds
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Pediatric health and respiratory diseases
  • Antioxidant Activity and Oxidative Stress
  • Plant-derived Lignans Synthesis and Bioactivity
  • Lipid metabolism and disorders
  • Hippo pathway signaling and YAP/TAZ
  • Traditional Chinese Medicine Analysis

Shandong University of Traditional Chinese Medicine
2024-2025

Guangzhou Medical University
2023-2024

Abstract Chronic obstructive pulmonary disease (COPD) is a serious chronic lung disease. Schisandrin A (SchA) one of the most important active ingredients in Schisandra chinensis and has been used to treat various diseases several countries. Here, we studied pharmacological effect SchA on airway inflammation induced by cigarette smoke (CS) explored therapeutic mechanism COPD model mice. Our results showed that treatment significantly improved function CS-induced mice reduced recruitment...

10.1186/s40001-023-01190-8 article EN cc-by European journal of medical research 2023-07-03

Background and Purpose Mitochondrial dysregulation of endothelial progenitor cells (EPCs) has been implicated in destruction hypertension. Regulation silent information regulator 3 (sirtuin 3; SIRT3) mitochondrial damage EPCs the underlying molecular mechanisms remain unclear, evidence selective SIRT3 agonists for treatment hypertension also is lacking. Experimental Approach Here, we discovered a potent agonist, rhynchophylline (Rhy), explored its action on dysfunction. Key Results In...

10.1111/bph.70032 article EN British Journal of Pharmacology 2025-03-31

Abstract Objective Quanzhen Yiqi decoction (QZYQ) is a traditional Chinese medicine for treating chronic obstructive pulmonary disease. Methods Mice were exposed to cigarette smoke (CS) 6 days/week (40 cigarettes/day) 24 weeks and then intragastrically administered QZYQ (4.72, 9.45, or 18.89 g/kg) dexamethasone (DEX, 0.6 mg/kg) weeks. We examined the lung function collected bronchoalveolar lavage fluid inflammatory cell cytokine quantification. The pathological changes, ROS oxidative...

10.1093/jpp/rgae047 article EN Journal of Pharmacy and Pharmacology 2024-04-26
Coming Soon ...